American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$389M |
| 2 |
Meta Platforms (Facebook)
META
|
+$296M |
| 3 |
Salesforce
CRM
|
+$207M |
| 4 |
Howmet Aerospace
HWM
|
+$122M |
| 5 |
Reinsurance Group of America
RGA
|
+$121M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$349M |
| 2 |
Visa
V
|
+$249M |
| 3 |
IQVIA
IQV
|
+$234M |
| 4 |
T-Mobile US
TMUS
|
+$226M |
| 5 |
NXP Semiconductors
NXPI
|
+$212M |
Sector Composition
| 1 | Technology | 23.35% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
2651
DELISTED
Inozyme Pharma
INZY
| $68K | ﹤0.01% |
+12,200
| New | +$68K |
|
2652
Annexon
ANNX
$243M
| $67.3K | ﹤0.01% |
19,128
+9,061
| +90% | +$31.9K |
|
2653
Tile Shop Holdings
TTSH
$282M
| $67.1K | ﹤0.01% |
12,119
-3,484
| -22% | -$19.3K |
|
2654
Microvast
MVST
$932M
| $67K | ﹤0.01% |
41,860
+22,226
| +113% | +$35.6K |
|
2655
Altice USA
ATUS
$1.05B
| $66.4K | ﹤0.01% |
22,000
+56
| +0.3% | +$169 |
|
2656
C4 Therapeutics
CCCC
$193M
| $65.9K | ﹤0.01% |
23,953
+9,292
| +63% | +$25.6K |
|
2657
Sensus Healthcare
SRTS
$53.1M
| $64.6K | ﹤0.01% |
20,516
+2,234
| +12% | +$7.04K |
|
2658
Bioventus
BVS
$482M
| $63.8K | ﹤0.01% |
22,073
+4,370
| +25% | +$12.6K |
|
2659
TrueCar
TRUE
$195M
| $62.5K | ﹤0.01% |
27,657
+14,495
| +110% | +$32.8K |
|
2660
Energy Vault
NRGV
$312M
| $60.6K | ﹤0.01% |
+22,201
| New | +$60.6K |
|
|
NIU
2661
Niu Technologies
NIU
$342M
| $60.6K | ﹤0.01% |
15,226
| – | – |
|
2662
ATAI Life Sciences
ATAI
$969M
| $60K | ﹤0.01% |
34,907
+11,014
| +46% | +$18.9K |
|
2663
MacroGenics
MGNX
$111M
| $59.3K | ﹤0.01% |
11,088
-7,177
| -39% | -$38.4K |
|
2664
Alto Ingredients
ALTO
$88.2M
| $58K | ﹤0.01% |
20,086
+5,492
| +38% | +$15.9K |
|
2665
Codexis
CDXS
$221M
| $56.1K | ﹤0.01% |
+20,028
| New | +$56.1K |
|
2666
Fossil Group
FOSL
$160M
| $55.8K | ﹤0.01% |
21,711
+10,219
| +89% | +$26.3K |
|
2667
BioAtla
BCAB
$35.9M
| $55.5K | ﹤0.01% |
+18,487
| New | +$55.5K |
|
|
TUYA
2668
Tuya Inc
TUYA
$1.57B
| $55.1K | ﹤0.01% |
29,178
| – | – |
|
2669
NextNav
NN
$2.1B
| $54.8K | ﹤0.01% |
18,629
-296
| -2% | -$870 |
|
2670
Purple Innovation
PRPL
$118M
| $54.1K | ﹤0.01% |
+19,474
| New | +$54.1K |
|
2671
China Automotive Systems
CAAS
$141M
| $50.8K | ﹤0.01% |
10,324
+69
| +0.7% | +$339 |
|
|
LL
2672
DELISTED
LL Flooring Holdings, Inc.
LL
| $50.4K | ﹤0.01% |
+13,165
| New | +$50.4K |
|
2673
Traeger
COOK
$197M
| $48.9K | ﹤0.01% |
+11,510
| New | +$48.9K |
|
2674
Ranpak Holdings
PACK
$416M
| $48K | ﹤0.01% |
+10,622
| New | +$48K |
|
|
SRTA
2675
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$327M
| $45.4K | ﹤0.01% |
+11,531
| New | +$45.4K |
|